Can a new stomach and gut bypass surgery tackle obesity and diabetes?

NCT ID NCT07765758

Not yet recruiting Disease control Sponsor: Medical City for Military and Security Services Source: ClinicalTrials.gov ↗

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests a new laparoscopic procedure called SIBS, which combines sleeve gastrectomy with a side-to-side connection between the duodenum and ileum, without cutting the duodenum. The goal is to see if the surgery is safe and technically feasible in adults with obesity and type 2 diabetes. Participants will be followed for up to 12 months to track weight loss, blood sugar control, and any complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Stapled Intact-Duodenum Bipartition with Sleeve Gastrectomy (SIBS), a laparoscopic surgical procedure
What this could lead to: If successful, this could offer a safer, simpler bariatric surgery option that improves weight loss and blood sugar control in people with obesity and type 2 diabetes.
What could go wrong: This is an early, single-center study with only 50 participants, so results may not apply broadly. Surgery carries risks like leaks, bleeding, or complications requiring further procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OBESITY TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Division of Bariatric and Metabolic Surgery, Medical City for Military and Security Services

Muscat, 111, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.